Anti-hypertensive effect of crocin and hesperidin combination in high-fat diet treated rats

Mahmoud Hashemzaei1, Ramin Rezaee2,3, Mojtaba Nabatzehi1

  • 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, 9861615881 Zabol, Iran.

Insights

Hesperidin (HES) and crocin (CRO) combination therapy shows promise in reducing blood pressure in a rat model of hypertension. This natural compound combination may offer a preventive strategy for hypertension development.

Area of Science:

  • Cardiovascular Research
  • Natural Product Pharmacology
  • Animal Models of Disease

Background:

  • Cardiovascular diseases are the leading global cause of mortality.
  • Hypertension is a primary risk factor for cardiovascular diseases.
  • Medicinal herbs offer a cost-effective alternative with fewer side effects for managing hypertension.

Purpose of the Study:

  • To investigate the antihypertensive effects of hesperidin (HES) and crocin (CRO) administered alone and in combination.
  • To evaluate these effects in a rat model of high-fat diet (HFD)-induced hypertension.
  • To compare the efficacy of HES and CRO with a combined therapeutic approach.

Main Methods:

  • Rats were fed a high-fat diet (HFD) for 7 weeks to induce hypertension.
  • Experimental groups received HFD with either CRO (20 mg/kg), HES (20 mg/kg), or a combination of CRO + HES (20 + 20 mg/kg).
  • Invasive measurements of mean arterial blood pressure (MAP), systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) were conducted via carotid artery cannulation.

Main Results:

  • HFD-induced hypertension significantly increased SBP, HR, and MAP compared to controls.
  • Combined administration of CRO + HES significantly reduced SBP, HR, and MAP in HFD-treated rats.
  • HES alone significantly decreased SBP, but MAP remained unaffected, while DBP was not significantly altered by any treatment.

Conclusions:

  • The simultaneous administration of crocin and hesperidin exhibits significant hypotensive effects in a rat model of HFD-induced hypertension.
  • These findings suggest that crocin and hesperidin are potential natural products for further investigation as preventive strategies against hypertension.
  • Further research is warranted, particularly for individuals with high-normal blood pressure.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
810
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
618